Jaquette Liljencrantz

Jaquette Liljencrantz

Auto-generated profile, based on publicly available information

Jaquette Liljencrantz

National Center for Complementary and Integrative Health, National Institutes of Health, Bethesda, MD 20892, USA

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 October 2018 in Science Translational Medicine
Verified
Journal Article
Closed access
PDF file
MSMarcin Szczot
Marcin Szczot
JLJaquette Liljencrantz
Jaquette Liljencrantz
NGNima Ghitani
Nima Ghitani
ABArnab Barik
Arnab Barik
RLRuby Lam
Ruby Lam
ACAlexander T. Chesler
Alexander T. Chesler
The stretch-gated ion channel PIEZO2 is required for inflammation-induced tactile allodynia.

5 July 2019 in Science Advances
Verified
Journal Article
Open access
PDF file
Saad NagiSaad Nagi
Saad Nagi
AMAndrew G. Marshall
Andrew G. Marshall
AMAdarsh Makdani
Adarsh Makdani
EJEwa Jarocka
Ewa Jarocka
JLJaquette Liljencrantz
Jaquette Liljencrantz
HOHåkan Olausson
Håkan Olausson
Pain can be signaled as fast as touch in human peripheral nerves.

18 July 2022 in Acta Neurologica Scandinavica
Verified
Journal Article
Open access
SWSandra Bjerkne Wenneberg
Sandra Bjerkne Wenneberg
LBLinda Block
Linda Block
ASAnn Sörbo
Ann Sörbo
SNSilvana Naredi
Silvana Naredi
JOJonatan Oras
Jonatan Oras
HHHelena Odenstedt Hergès
Helena Odenstedt Hergès
Objectives The survival rates for patients affected by aneurysmal subarachnoid hemorrhage (aSAH) have increased in recent years; however, many patients continue to develop cognitive dysfunctions that affect their quality of life. The commonly used outcome measures often fail to identify these cognitive dysfunctions. This study aimed to evaluate the long-term outcomes at 1 and 3 years after aSAH to assess changes over time and relate outcomes to patient characteristics and events during the acute phase. Materials and Methods This prospective observational study included patients that experienced aSAH. Patients were assessed according to the extended Glasgow Outcome Scale, Life Satisfaction Questionnaire, Mayo-Portland Adaptability inventory-4, and Mental Fatigue scale. Results Patients were assessed after 1 year (n = 62) and 3 years (n = 54). At 3 years, the extended Glasgow Outcome Scale score improved in 15% and worsened in 12% of the patients. Mental fatigue was observed in 57% of the patients at 1 year. Patients <60 years of age at the time of aSAH had more self-assessed problems, including pain/headache (p < .01), than patients >60 years of age. Patients with delayed cerebral ischemia during the acute phase reported more dissatisfaction at 3 years, whereas no significant result was seen at 1 year. Conclusions Cognitive dysfunction, especially mental fatigue, is common in patients with aSAH, which affects quality of life and recovery. Patient outcome is a dynamic process developing throughout years after aSAH, involving both improvement and deterioration. This study indicates the importance of longer follow-up periods with broad outcome assessments.

13 June 2020 in Acta Anaesthesiologica Scandinavica
Verified
Journal Article
Open access
PDF file
LBLinda Block
Linda Block
AEAli El‐Merhi
Ali El‐Merhi
JLJaquette Liljencrantz
Jaquette Liljencrantz
SNSilvana Naredi
Silvana Naredi
MSMiroslaw Staron
Miroslaw Staron
HHHelena Odenstedt Hergès
Helena Odenstedt Hergès
Background: The onset of cerebral ischemia is difficult to predict in patients with altered consciousness using the methods available. We hypothesize that changes in Heart Rate Variability (HRV), Near‐Infrared Spectroscopy (NIRS), and Electroencephalography (EEG) correlated with clinical data and processed by artificial intelligence (AI) can indicate the development of imminent cerebral ischemia and reperfusion, respectively. This study aimed to develop a method that enables detection of imminent cerebral ischemia in unconscious patients, noninvasively and with the support of AI.Methods: This prospective observational study will include patients undergoing elective surgery for carotid endarterectomy and patients undergoing acute endovascular embolectomy for cerebral arterial embolism. HRV, NIRS, and EEG measurements and clinical information on patient status will be collected and processed using machine learning. The study will take place at Sahlgrenska University Hospital, Gothenburg, Sweden. Inclusion will start in September 2020, and patients will be included until a robust model can be constructed. By analyzing changes in HRV, EEG, and NIRS measurements in conjunction with cerebral ischemia or cerebral reperfusion, it should be possible to train artificial neural networks to detect patterns of impending cerebral ischemia. The analysis will be performed using machine learning with long short‐term memory artificial neural networks combined with convolutional layers to identify patterns consistent with cerebral ischemia and reperfusion.Discussion: Early signs of cerebral ischemia could be detected more rapidly by identifying patterns in integrated, continuously collected physiological data processed by AI. Clinicians could then be alerted, and appropriate actions could be taken to improve patient outcomes.

1 January 2025 in Acta Neurologica Scandinavica
Verified
Journal Article
Open access
SWSandra Bjerkne Wenneberg
Sandra Bjerkne Wenneberg
LBLinda Block
Linda Block
JOJonatan Oras
Jonatan Oras
PHPia Löwhagen Hendén
Pia Löwhagen Hendén
JLJaquette Liljencrantz
Jaquette Liljencrantz
HHHelena Odenstedt Hergès
Helena Odenstedt Hergès
Objectives: Mental fatigue is a common and debilitating symptom following an aneurysmal subarachnoid hemorrhage (aSAH). However, its long‐term prevalence and consequences remain unclear. In this longitudinal pilot study, the Mental Fatigue Scale (MFS) was used to evaluate the prevalence, severity, and dynamics of mental fatigue for up to 5 years and to correlate patient demographics and early complications to the development of mental fatigue. Method : Functional outcomes were scored using the Glasgow Outcome Scale‐Extended (GOSE) during telephone interviews 1, 3, and 5 years after aSAH. The MFS questionnaires (maximum score 42, ≥ 10.5 points indicating mental fatigue) were subsequently sent by mail. Patient admission data and events during the acute phase were recorded. Results: Of 64 included patients, 31 could be assessed at all time points. Mental fatigue (MFS score ≥ 10.5) was present in 58%, 48%, and 52% of the patients at 1, 3, and 5 years, respectively. A significant decrease in the total MFS score was observed between 1 and 5 years ( p = 0.025). The proportion of patients experiencing severe mental fatigue halved from 1 to 3 years. The median (range) MFS scores were significantly higher for women (14.5, 0–29.5) than for men (3, 0–17.5) at 1 year ( p = 0.043). Compared with patients experiencing loss of consciousness at ictus (LOCi), those without LOCi exhibited a progressive decline in the total MFS score ( p = 0.003). Conclusions: Although total MFS scores significantly improved, mental fatigue was a common and persistent symptom affecting half of the patients up to 5 years following aSAH. Mental fatigue was more prevalent in women than men; further, patients who experienced LOCi during the acute phase improved less over time. Our results highlight the importance of evaluating mental fatigue when assessing patient recovery and long‐term outcomes. Trial Registration: Clinical Trial NCT06239142

2 December 2023
Verified
Book Chapter
Closed access
PDF file
AHAlex Helmersson
Alex Helmersson
FHFaton Hoti
Faton Hoti
SLSebastian Levander
Sebastian Levander
ASAliasgar Shereef
Aliasgar Shereef
ESEmil Svensson
Emil Svensson
MSMiroslaw Staron
Miroslaw Staron